The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease

BACKGROUND/AIMS: Idiopathic multicentric Castleman disease (iMCD) comprises approximately 30% of all cases of Castleman disease. It is characterized by constitutional symptoms, enlarged lymph nodes at multiple anatomical sites, and laboratory test abnormalities, which are primarily related to the ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Gi-June, Jeon, Young-Woo, Park, Sung-Soo, Park, Silvia, Shin, Seung-Hawn, Yahng, Seung-Ah, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Kim, Hee-Je, Min, Chang-Ki, Kim, Dong-Wook, Lee, Jong-Wook, Cho, Seok-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969064/
https://www.ncbi.nlm.nih.gov/pubmed/32088937
http://dx.doi.org/10.3904/kjim.2019.330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969064/
https://www.ncbi.nlm.nih.gov/pubmed/32088937
http://dx.doi.org/10.3904/kjim.2019.330

Ejemplares similares